28/06/2026
๐ธ๐ฆ Sharing our vision for the future of at .
At the Saudi Pavilion during the BIO International Convention 2026 in San Diego, our CEO, Mr. Bruce Gurfein, took the stage to present KaRama VS investment for ุฑุคูุฉ ุงูุณุนูุฏูุฉ 2030 โ a roadmap for building and scaling science-driven ventures that bring world-class MedTech and BioTech innovation to the Kingdom.
At the heart of our model is a simple conviction: the Kingdom shouldn't only adopt the next generation of health technologies โ it should discover, develop, and manufacture them. Through our shared IP and R&D venture-studio approach, we invest across biomarker discovery, longevity, digital health, and access, partnering with leading scientific and clinical institutions to localize and originate breakthroughs. Made in KSA. Invented in KSA.
This is how we turn the ambition of ุฑุคูุฉ ุงูุณุนูุฏูุฉ 2030 into tangible capabilities, and BIO 2026 has been a powerful stage to share that journey with the global life-sciences community.
Thank you to the Ministry of Health Saudi Arabia, and the Saudi Biotech delegation for creating the platform for Saudi innovation to lead on the world stage.